E33-23969-51065 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-14
Dose 1 — Pfizer-BioNTech
2021-05-05
Dose 2 — Pfizer-BioNTech
2021-12-10
Dose 3 — Moderna
2021-12-11
Registered in v-safe
2021-12-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-12-12
Survey response — days 1–6 daily, dose 3
MedDRA: Injection site pain — Feeling: Good

Free text: Sore arm at injection site

MedDRA releases: 2024-11 · check-in free text available
2021-12-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-16
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-24
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-31
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-14	Pfizer-BioNTech	No
2	2021-05-05	Pfizer-BioNTech	No
3	2021-12-10	Moderna	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-12

Systemic reaction (other): Sore arm at injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Injection site pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release